Eija Eloranta
University of Oulu
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eija Eloranta.
The Journal of Clinical Endocrinology and Metabolism | 2010
Adrian Daly; Maria A. Tichomirowa; Patrick Petrossians; Elina Heliövaara; Marie Lise Jaffrain-Rea; Anne Barlier; Luciana A. Naves; Tapani Ebeling; Auli Karhu; Antti Raappana; Laure Cazabat; Ernesto De Menis; Carmen Fajardo Montañana; Gérald Raverot; Robert J. Weil; Timo Sane; Dominique Maiter; Sebastian Neggers; Maria Yaneva; Antoine Tabarin; Elisa Verrua; Eija Eloranta; Arnaud Murat; Outi Vierimaa; Pasi I. Salmela; Philippe Emy; Rodrigo A. Toledo; María Isabel Sabaté; Chiara Villa; Marc Popelier
CONTEXT AIP mutations (AIPmut) give rise to a pituitary adenoma predisposition that occurs in familial isolated pituitary adenomas and less often in sporadic cases. The clinical and therapeutic features of AIPmut-associated pituitary adenomas have not been studied comprehensively. OBJECTIVE The objective of the study was to assess clinical/therapeutic characteristics of AIPmut pituitary adenomas. DESIGN This study was an international, multicenter, retrospective case collection/database analysis. SETTING The study was conducted at 36 tertiary referral endocrine and clinical genetics departments. PATIENTS Patients included 96 patients with germline AIPmut and pituitary adenomas and 232 matched AIPmut-negative acromegaly controls. RESULTS The AIPmut population was predominantly young and male (63.5%); first symptoms occurred as children/adolescents in 50%. At diagnosis, most tumors were macroadenomas (93.3%); extension and invasion was common. Somatotropinomas comprised 78.1% of the cohort; there were also prolactinomas (n = 13), nonsecreting adenomas (n = 7), and a TSH-secreting adenoma. AIPmut somatotropinomas were larger (P = 0.00026), with higher GH levels (P = 0.00068), more frequent extension (P = 0.018) and prolactin cosecretion (P = 0.00023), and occurred 2 decades before controls (P < 0.000001). Gigantism was more common in the AIPmut group (P < 0.000001). AIPmut somatotropinoma patients underwent more surgical interventions (P = 0.00069) and had lower decreases in GH (P = 0.00037) and IGF-I (P = 0.028) and less tumor shrinkage with somatostatin analogs (P < 0.00001) vs. controls. AIPmut prolactinomas occurred generally in young males and frequently required surgery or radiotherapy. CONCLUSIONS AIPmut pituitary adenomas have clinical features that may negatively impact treatment efficacy. Predisposition for aggressive disease in young patients, often in a familial setting, suggests that earlier diagnosis of AIPmut pituitary adenomas may have clinical utility.
Evolution | 1989
Ilpo Kojola; Eija Eloranta
Maternal ability to invest in reproduction influences progeny sex ratio according to the expected dependence of lifetime reproductive success on offspring condition when this dependence varies between sexes
Physiological and Biochemical Zoology | 2001
H. Säkkinen; Audun Stien; Øystein Holand; K. Hove; Eija Eloranta; Seppo Saarela; Erik Ropstad
Variation in plasma urea and creatinine concentration and plasma urea:creatinine ratio (U:C) were studied in semidomestic free‐ranging reindeer (Rangifer tarandus tarandus) on the Norwegian mainland, in wild Svalbard reindeer (Rangifer tarandus platyrhynchus), and in captive reindeer maintained either on a lichen‐based diet or a protein‐rich concentrate to investigate whether these parameters could be used as indicators of the nutritional status of reindeer. In the mainland animals, plasma creatinine concentration was high in winter and early spring and decreased by two‐thirds toward the summer. The overall range in mean plasma creatinine concentration (±SE) was from \documentclass{aastex} \usepackage{amsbsy} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{bm} \usepackage{mathrsfs} \usepackage{pifont} \usepackage{stmaryrd} \usepackage{textcomp} \usepackage{portland,xspace} \usepackage{amsmath,amsxtra} \usepackage[OT2,OT1]{fontenc} \newcommand\cyr{ \renewcommand\rmdefault{wncyr} \renewcommand\sfdefault{wncyss} \renewcommand\encodingdefault{OT2} \normalfont \selectfont} \DeclareTextFontCommand{\textcyr}{\cyr} \pagestyle{empty} \DeclareMathSizes{10}{9}{7}{6} \begin{document} \landscape
Theriogenology | 2004
Seija Vahtiala; H. Säkkinen; Ellen Dahl; Eija Eloranta; J.F. Beckers; Erik Ropstad
Rangifer | 1990
Ilpo Kojola; Eija Eloranta
90\pm 1.26
Animal Science | 2005
H. Säkkinen; J. Tornberg; P. J. Goddard; Eija Eloranta; Ellen Dahl; Erik Ropstad; Seppo Saarela
Comparative Biochemistry and Physiology B | 1999
Heidi Vierimaa; Mirja-Liisa Sassi; Eija Eloranta; Markku Rahiala; Jouni Timisjärvi; Seppo Saarela; Juha Risteli
\end{document} to \documentclass{aastex} \usepackage{amsbsy} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{bm} \usepackage{mathrsfs} \usepackage{pifont} \usepackage{stmaryrd} \usepackage{textcomp} \usepackage{portland,xspace} \usepackage{amsmath,amsxtra} \usepackage[OT2,OT1]{fontenc} \newcommand\cyr{ \renewcommand\rmdefault{wncyr} \renewcommand\sfdefault{wncyss} \renewcommand\encodingdefault{OT2} \normalfont \selectfont} \DeclareTextFontCommand{\textcyr}{\cyr} \pagestyle{empty} \DeclareMathSizes{10}{9}{7}{6} \begin{document} \landscape
Archive | 1992
Eija Eloranta; Jouni Timisjärvi; Mauri Nieminen; Juhani Leppäluoto; Olli Vakkuri
Rangifer | 1990
Jouni Timisjärvi; Mauri Nieminen; Juhani Leppäluoto; T. Lapinlampi; P. Saukko; Eija Eloranta; P. Soppela
280\pm 2.88
Rangifer | 1986
Eija Eloranta; Mauri Nieminen